Board Meeting19 Oct 2026, 06:30 pm
Eris Lifesciences Board Meeting on Oct 26 to Approve Financial Results
AI Summary
Eris Lifesciences Ltd has announced that its Board of Directors will convene on October 26, 2026. The primary agenda item for this meeting is to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2026. The company also confirmed that the trading window, which closed on October 1, 2026, will remain shut until 48 hours after the financial results are declared, in compliance with SEBI regulations.
Key Highlights
- Board meeting scheduled for October 26, 2026.
- To approve standalone and consolidated financial results.
- Results are for the quarter and half-year ended September 30, 2026.
- Unaudited financial results will be presented.
- Trading window closure extended post-results declaration.
Price Impact
More from ERIS